Intrinsic Activity, 2015; 3(Suppl. 2): A7.3
doi:10.25006/IA.3.S2-A7.3
From:
21st Scientific Symposium of the Austrian Pharmacological Society.
Joint Meeting with the British Pharmacological Society and the Pharmacological Societies of Croatia, Serbia and Slovenia
Graz, 16 – 18 September 2015
MEETING ABSTRACT
Intrinsic Activity,
2015; 3(Suppl. 2):

Content page
Author index

A7.3
Deuteration changes the binding of some histaminergic agonists to the histamine H2 receptor in astrocytes
Mojca Kržan1,* and Janez Mavri2
  1. Department of Pharmacology and Experimental Toxicology, Faculty of Medicine, University of Ljubljana, Slovenia
  2. National Institute of Chemistry, Ljubljana, Slovenia
* Corresponding author: e-mail

Background: A crucial step in the binding of histaminergic ligands, e. g. histamine to the H2 receptor, is the formation of three hydrogen bonds between amino acid residues (Asp98, Asp186 and Thr190) present in the third and the fifth transmembrane α-helices and three nitrogen atoms of the histamine molecule. In order to estimate the relevance of hydrogen bonds in the process of binding of ligands to the H2 receptor we compared the binding properties of [3H]tiotidine to histamine H2 receptor binding sites in cultured neonatal rat astrocytes in control and deuterated medium.

Methods: To test this hypothesis we performed saturation and inhibition binding studies using [3H]tiotidine as a biomarker in cultured glial cells. We modeled changed binding affinity upon deuteration of histamine in conjunction with quantum chemical calculations and quantization of nuclear motion of the protons involved in hydrogen bonding.

Results: [3H]tiotidine binds in a reversible and saturable manner to a single population of binding sites with maximal binding-site density (Bmax) of 22.0 ± 3.2 fmol/mg protein and equilibrium dissociation constant (Kd) of 6.3 ± 1.9 nM. Histamine, 2-methylhistamine and 4-methylhistamine displaced the radioligand with pIC50 values of 7.6 ± 0.14, 8.5 ± 0.16, and 7.4 ± 0.25, respectively. Binding characteristics changed upon deuteration: the Bmax dropped nonsignificantly to 17.4 ± 5.2 fmol/mg protein; the Kd of [3H]tiotidine changed to 8.6 ± 5.0 nM (p > 0.05; determined by Student’s t-test; n = 6); the pIC50 values for histamine, 2-methylhistamine and 4-methylhistamine in deuterated conditions were 8.0 ± 0.15, 6.8 ± 0.16 (p < 0.05; Student’s t-test; n = 6) and 7.7 ± 0.13, respectively (n = 6). The experimental data show that deuteration significantly attenuated binding free energy of 2-methylhistamine (2.15 kcal/mol), but decreased binding free energy for 4-methylhistamine (−0.51 kcal/mol) and histamine (−0.78 kcal/mol). Ab initio calculations of the isotope effect were performed for the endogenous ligand histamine for transfer of monoprotonated histamine ion from the aqueous environment to the receptor binding site. Implicitly quantized NH and OH motion revealed that the changes can be rationalized by attenuated strength of hydrogen bonding upon deuteration which is known as Ubbelohde effect.

Discussion: Replacing hydrogen atoms involved in binding of histamine ligands to H2 receptor binding sites with deuterium atoms results in different length of intermolecular and intramolecular distances. This leads to a structural change of ligand and receptor binding sites which significantly affects the binding affinities of methylhistamines The effects of deuteration on the affinity is the difference between the interaction free energy receptor–ligand and water–ligand giving rise to increased or decreased values. Our study offers a simple and practical approach how to treat nuclear quantum effects in drug–receptor binding and will hopefully help reaching a distant goal that is in silico discrimination between agonists and antagonists.

Acknowledgements: The work was supported grants no. J1-2014, P3-067 and P1-012 of the Slovenian Research Agency.

open the PDF file

published online:
9 September 2015